Clinical Trial Update: Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toripalimab in combination with radiotherapy for oligometastatic nasopharyngeal carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING